Relative importance of oral versus intravenous vancomycin exposure in the development of vancomycin-resistant enterococci [3]

Journal of Infectious Diseases

Volumn 173, Issue 5, 1996, Pages 1292-1294

  Luber, A D ^a   Jacobs, R A ^a   Jordan, M ^a   Guglielmo, B J ^a   Shay, D K ^a   Jarvis, W R ^a   Montecalvo, M ^a  

^a UCSF Medical Center and Associate Clinical UCSF School of Pharmacy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; CEPHALOSPORIN; PENICILLIN G; QUINOLONE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIAL COLONIZATION; CRITICAL ILLNESS; ENTEROCOCCUS; HIGH RISK PATIENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0029945140     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.5.1292     Document Type: Letter

References (0)